Humana (HUM ) Tops Q2 EPS by 4c, Reaffirms FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Humana Reports Second Quarter 2015 Financial Results; Reaffirms 2015 Financial Guidance
July 29, 2015 7:30 AM EDT2Q 2015 EPS of $2.85 includes $1.18 of gain related to sale of Concentra 2Q 2015 Adjusted EPS of $1.67 excludes the Concentra 2Q 2015 gain and compares to managements guidance of $1.60 to $1.65 Reaffirmed full-year 2015 EPS guidance of approximately $9.28 or $7.75 on an Adjusted basis (excluding the year-to-date gain on sale of Concentra of $1.53 per share) 2Q 2015 Medicare Advantage utilization seen as stabilizing and tracking with managements revised expectations Actions taken to improve profitability of individual commercial and state-based contracts businesses
... More
